Cookies on Leisure Tourism

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

>>> Sign up to receive our Leisure, Hospitality & Tourism e-newsletter, book alerts, and offers <<<

Results per page:

Search results

Abstract

Introduction: Malaria prevention can be complex due to the individual characteristics of the traveller, travel destination, duration of stay and type of travel. Our aim in this study was to document malaria chemoprophylaxis recommendations provided by travel-medicine experts in Europe for specific...

Author(s)
Shellvarajah, M.; Hatz, C.; Schlagenhauf, P.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Travel Medicine and Infectious Disease, 2017, 19, pp 49-55
Abstract

Background: Chemoprophylaxis against falciparum malaria is recommended for travellers from non-endemic countries to malarious destinations, but debate continues on benefit, especially with regard to mefloquine. Quantification of benefit for travellers from the United Kingdom (UK) was modelled to...

Author(s)
Toovey, S.; Nieforth, K.; Smith, P.; Schlagenhauf, P.; Adamcova, M.; Tatt, I.; Tomianovic, D.; Schnetzler, G.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Travel Medicine and Infectious Disease, 2014, 12, 6, Part B, pp 726-732
Abstract

Objectives: Complete prevention of malaria especially Plasmodium falciparum is the goal of prophylaxis. A survey, designed to ascertain reasons behind the choice of malaria prophylaxis, compliance and side effects, and to gather data on acquired malaria, identified a cluster of Plasmodium vivax...

Author(s)
Mavrogordato, A.; Lever, A. M. L.
Publisher
Elsevier Ltd, Oxford, UK
Citation
Journal of Infection, 2012, 65, 3, pp 269-274
Abstract

What is already known on this topic Malaria is a potentially life-threatening disease, and cases of imported Plasmodium falciparum malaria have increased among UK travellers over the past 20 years, although declining steadily in recent years. The HPA Advisory Committee on Malaria Prevention (ACMP)...

Author(s)
Zuckerman, J. N.; Batty, A. J.; Jones, M. E.
Publisher
Elsevier, Amsterdam, Netherlands
Citation
Travel Medicine and Infectious Disease, 2009, 7, 6, pp 329-336
Abstract

Atovaquone-proguanil has been shown to be effective and well tolerated for malaria prophylaxis in residents of countries of endemicity and in nonimmune adult travelers, but data about traveling children are limited. In a randomized, open-label, multicenter prophylaxis trial, 221 nonimmune pediatric ...

Author(s)
Camus, D.; Djossou, F.; Schilthuis, H. J.; Høgh, B.; Dutoit, E.; Malvy, D.; Roskell, N. S.; Hedgley, C.; Boever, E. H. de; Miller, G. B.
Publisher
University of Chicago Press, Chicago, USA
Citation
Clinical Infectious Diseases, 2004, 38, 12, pp 1716-1723
Abstract

An update on the prevention and control of malaria (Plasmodium) in travellers from the UK is presented, with reference to the risk of exposure to malaria, geographical risks (Sierra Leone is currently top of the list with >50 cases of malaria reported for every 10 000 visits), bite prevention,...

Author(s)
Evans, M. R. W.; Day, J. H.; Behrens, R. H.
Citation
Hospital Medicine, 2000, 61, 3, pp 162-166

Refine Results

Sort Order
Author
Geographical Location
Organisms
Subject Topics